Product Information
MELOXICAM 5 MG CAPSULE is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $9.5108 per EA under NDC 68180018806. Its NADAC has been published 123 times since Apr 17, 2024.
FDA first approved this application on Jun 1, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Meloxicam market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
5 mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180018806
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
MELOXICAMApproval Type
Generic (ANDA)
FDA Application
ANDA209487FDA Approved
6/1/2020
TE Code
AB
On Market Since
12/22/2020
Pharmacological Classes
Price Statistics
The NADAC for MELOXICAM 5 MG CAPSULE has been published 123 times since Apr 17, 2024, and over the history we have for it it has declined 2.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.5108 per EA |
|---|---|
| All-time high | $14.4106 (Jul 16, 2025) |
| All-time low | $7.4004 (Jun 19, 2024) |
| 52-week high | $12.0214 |
| 52-week low | $8.2582 |
| Median price | $9.7116 |
| Average price | $9.9882 |
| Largest weekly change | +21.1% (Jul 17, 2024) |
| Weeks tracked | 123 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MELOXICAM 5 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for MELOXICAM 5 MG CAPSULE, manufactured by Lupin Pharmaceuticals Inc., is $9.5108 per EA (NDC 68180018806), effective Aug 19, 2026.
How has the price of MELOXICAM 5 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for MELOXICAM 5 MG CAPSULE has declined 2.1%. It has been tracked across 123 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for MELOXICAM 5 MG CAPSULE?
Since Apr 17, 2024, the NADAC for MELOXICAM 5 MG CAPSULE has ranged from a low of $7.4004 (Jun 19, 2024) to a high of $14.4106 (Jul 16, 2025), with a median of $9.7116 per EA.
Are there cheaper alternatives to MELOXICAM 5 MG CAPSULE?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as MELOXICAM 5 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures MELOXICAM 5 MG CAPSULE?
MELOXICAM 5 MG CAPSULE (NDC 68180018806) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.